Standout Papers

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment 2014 2026 2018 2022 363
  1. Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment (2014)
    E. Blind, Kristina Dunder et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 7 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Climate Change, Extreme Heat, and Health
2024 Standout
3 intermediate papers

Works of T. Bourcier being referenced

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
2014 Standout
HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells
2000

Author Peers

Author Last Decade Papers Cites
T. Bourcier 317 85 44 352 227 11 725
Motofumi Sasaki 174 88 30 325 200 16 759
Julia Möllmann 188 175 87 357 284 21 796
Anne Q. Reuwer 326 38 16 316 194 24 746
John A. Krawiec 183 66 10 260 442 9 826
Nobuo Kajitani 158 57 43 330 167 10 628
Ryo Kodera 185 46 37 360 169 16 632
Harshini Mudaliar 144 114 34 283 207 9 662
Amanda Mather 262 55 49 492 267 22 786
Shaila P. Handattu 420 143 16 292 291 21 816
Birming Wong 169 102 30 217 255 7 638

All Works

Loading papers...

Rankless by CCL
2026